Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial
Janus激酶1/2抑制剂KL130008治疗活动性类风湿性关节炎的疗效和安全性：一项随机、双盲、安慰剂对照的II期试验
期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04566-1
Cheng, Yue; Tang, Honghu; Qing, Yufeng; Liu, Yuan; Yang, Lei; Dang, Wantai; Yu, Jing; Li, Rongbin; Liu, Huaxiang; Jiang, Zhenyu; Sun, Hongsheng; Yin, Songlou; Cheng, Jianzhao; Li, Zhijun; Fan, Wenqiang; Zhang, Hong; Du, Hongwei; Fu, Zili; Ma, Xinmei; Wu, Jian; Duan, Lihua; Zhang, Rong; Lin, Jinying; Da, Zhanyun; Wei, Wei; Zhai, Qianxun; Wu, Bingjie; Yi, Xiaowei; Jin, Xiaoping; Ge, Junyou; Feng, Ping; Liu, Yi
